Evaluation of Efficacy and Safety of VX-548 for Painful Diabetic Peripheral Neuropathy (DPN)

NCT05660538 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

194

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Peripheral Neuropathy

Interventions

DRUG: Suzetrigine
DRUG: Pregabalin
DRUG: Placebo (matched to SUZ)
DRUG: Placebo (matched to pregabalin)

Sponsor

Vertex Pharmaceuticals Incorporated